Related Experiment Video
Updated: Feb 4, 2026

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
Systems Pharmacology: Defining the Interactions of Drug Combinations
J G Coen van Hasselt1,2, Ravi Iyengar1
1Department of Pharmacological Sciences, Systems Biology Center, Mount Sinai Institute for Systems Biomedicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA;
Abstract:
The majority of diseases are associated with alterations in multiple molecular pathways and complex interactions at the cellular and organ levels. Single-target monotherapies therefore have intrinsic limitations with respect to their maximum therapeutic benefits. The potential of combination drug therapies has received interest for the treatment of many diseases and is well established in some areas, such as oncology. Combination drug treatments may allow us to identify synergistic drug effects, reduce adverse drug reactions, and address variability in disease characteristics between patients. Identification of combination therapies remains challenging. We discuss current state-of-the-art systems pharmacology approaches to enable rational identification of combination therapies. These approaches, which include characterization of mechanisms of disease and drug action at a systems level, can enable understanding of drug interactions at the molecular, cellular, physiological, and organismal levels. Such multiscale understanding can enable precision medicine by promoting the rational development of combination therapy at the level of individual patients for many diseases.
Insights
Combination drug therapies offer improved treatment by targeting multiple pathways, unlike single-drug approaches. Systems pharmacology enables rational identification of these complex therapies for personalized medicine.
Area of Science:
- Pharmacology
- Systems Biology
- Precision Medicine
Background:
- Most diseases involve complex molecular and cellular interactions, limiting single-target drug effectiveness.
- Combination drug therapies show promise for enhanced efficacy and reduced side effects, but identifying optimal combinations is difficult.
Purpose of the Study:
- To discuss state-of-the-art systems pharmacology approaches for the rational identification of combination drug therapies.
- To highlight the potential of systems pharmacology in understanding drug interactions across multiple biological levels.
Main Methods:
- Characterizing disease mechanisms and drug actions at a systems level.
- Analyzing drug interactions at molecular, cellular, physiological, and organismal scales.
- Utilizing systems pharmacology for a multiscale understanding of disease and treatment.
Main Results:
- Systems pharmacology enables a comprehensive understanding of drug interactions.
- Multiscale analysis reveals potential synergistic effects and reduced adverse reactions.
- Rational identification of combination therapies can be achieved through these advanced approaches.
Conclusions:
- Systems pharmacology is crucial for advancing combination drug therapy development.
- This approach facilitates precision medicine by enabling patient-specific combination treatments.
- Understanding complex disease pathways is key to unlocking the full potential of combination therapies.
More Related Videos
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Pharmacokinetics: Drug–Drug Interactions
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

